Biomedical, Biopharma and Clinical Research

Biography

Bekir Cinar completed his Postdoctoral Fellowship, Boston Children’s Hospital, Harvard Medical School (HMS), Boston, MA (2002-2006) and Ph.D. from Department of Biochemistry and Molecular Genetics, School of Medicine University of Virginia, Charlottesville, VA (1995-2002), D.V.M., Veterinary Medical School, Ankara University, Ankara, Turkey (1987-1992). Currently he is working as Associate Professor, Department of Biological Sciences, Clark Atlanta University (CAU), Atlanta, GA 2015 to present. Presently, He is also member of the Center for Cancer Research and Therapeutic Development at CAU and a member of the NCI-designated Winship Comprehensive Cancer Center at Emory University. Prior to joining CAU, Dr. Cinar was Assistant Professor of Medicine-Hematology/Oncology and Biomedical Sciences at Cedars-Sinai Medical Center, where he was a member of Samuel Oschin Comprehensive Cancer Institute.

Research Interest

His research focus is on signal transduction and gene expression mechanisms relevant to cancer development, progression, metastasis, and therapeutic resistance in disease models, particularly prostate cancer, which is a leading causes of cancer deaths among men in the United States and Western countries. Currently, my laboratory studies the Hippo-YAP-AR signaling axis to understand the molecular mechanisms of prostate cancer progression, metastasis and acquired resistance. His laboratory utilizes variety of complementary approaches including proteomics, genomics and bioinformatics as well cell cultures including 3D cultures, animal models and clinical samples to carry out the proposed research. His research focus is on Signal Transduction, gene Expression, genomics, Proteomics, Bioinformatics, 3DCell Cultures